Approximately 73,000 NEW cases of renal cell carcinoma (RCC) are expected to be diagnosed in 2019 in the United States, with up to 70% of these cases anticipated to be clear-cell subtype.
Jade L. Kutzke, PharmD
Advertisement
Articles by Jade L. Kutzke, PharmD
Advertisement
Latest Updated Articles
Clinical Insights: Use of Combination Therapy for Advanced Clear-Cell Renal Cell CarcinomaPublished: February 29th 2020 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
A Common Virus May Hold New Clues to Lupus
2
Expert Discusses Logistical Considerations and Future Research Needs for Radiopharmaceuticals
3
Zongertinib Shows Clinically Meaningful Efficacy in Advanced HER2-Mutant NSCLC
4
SHR-A1811 Plus Pertuzumab Improves Survival in HER2-Positive Metastatic Breast Cancer
5
